IRIS
PEDICA, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.716
NA - Nord America 2.442
AS - Asia 2.394
SA - Sud America 394
Continente sconosciuto - Info sul continente non disponibili 205
AF - Africa 49
OC - Oceania 5
Totale 8.205
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.263
RU - Federazione Russa 1.409
SG - Singapore 931
CN - Cina 735
IT - Italia 658
BR - Brasile 315
HK - Hong Kong 234
VN - Vietnam 182
DE - Germania 131
FR - Francia 116
GB - Regno Unito 97
BD - Bangladesh 95
CA - Canada 87
IN - India 64
FI - Finlandia 62
SE - Svezia 55
NL - Olanda 45
MX - Messico 41
PL - Polonia 32
AT - Austria 31
AR - Argentina 27
JP - Giappone 26
ES - Italia 17
TR - Turchia 17
IQ - Iraq 15
ZA - Sudafrica 15
JM - Giamaica 14
EC - Ecuador 12
ID - Indonesia 11
IE - Irlanda 10
LT - Lituania 10
PK - Pakistan 10
CR - Costa Rica 9
VE - Venezuela 9
CO - Colombia 8
MY - Malesia 8
UZ - Uzbekistan 8
BE - Belgio 7
CH - Svizzera 7
TT - Trinidad e Tobago 7
MA - Marocco 6
NI - Nicaragua 6
PY - Paraguay 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
IR - Iran 5
KE - Kenya 5
RO - Romania 5
TH - Thailandia 5
TN - Tunisia 5
TW - Taiwan 5
UA - Ucraina 5
AO - Angola 4
AU - Australia 4
CL - Cile 4
DK - Danimarca 4
NP - Nepal 4
PE - Perù 4
PH - Filippine 4
PS - Palestinian Territory 4
SA - Arabia Saudita 4
SV - El Salvador 4
AL - Albania 3
GH - Ghana 3
KR - Corea 3
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
CY - Cipro 2
HN - Honduras 2
IL - Israele 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LC - Santa Lucia 2
MD - Moldavia 2
OM - Oman 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
GY - Guiana 1
JO - Giordania 1
KN - Saint Kitts e Nevis 1
MK - Macedonia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
Totale 7.996
Salva come PNG Salva come JPEG
Città #
Singapore 607
Ashburn 373
San Jose 341
Moscow 266
Hong Kong 227
Milan 186
Dallas 159
Beijing 132
Shanghai 124
Council Bluffs 106
Hefei 81
Los Angeles 76
New York 73
Lauterbourg 72
Santa Clara 62
Ho Chi Minh City 61
Phoenix 52
Rome 51
Boardman 45
Hanoi 38
Munich 36
São Paulo 35
Orem 30
Warsaw 28
Helsinki 27
London 27
Nuremberg 26
Atlanta 25
Montreal 24
Brooklyn 22
Frankfurt am Main 22
Houston 22
Lappeenranta 22
Denver 19
Mexico City 19
Tokyo 19
Vienna 19
Guangzhou 17
Miano 17
Toronto 17
Chennai 16
Chicago 16
Boston 14
Philadelphia 14
Johannesburg 13
Turku 13
Seattle 12
Stockholm 12
Amsterdam 11
Ankara 11
Falkenstein 11
Genoa 11
Lawrence 11
Poplar 11
Princeton 11
Romagnano Sesia 11
Bologna 10
San Francisco 10
Buffalo 9
Cagliari 9
Cesano Boscone 9
Da Nang 9
Dublin 9
Kingston 9
Paris 9
Turin 9
Baghdad 8
Belo Horizonte 8
Monza 8
Naples 8
North Bergen 8
Tashkent 8
Bexley 7
Brussels 7
City of London 7
Dhaka 7
Florence 7
Haiphong 7
Las Vegas 7
Manchester 7
Mugnano di Napoli 7
Mumbai 7
Ottawa 7
Rio de Janeiro 7
San José 7
Shenzhen 7
Trento 7
Washington 7
Xi'an 7
Bergamo 6
Charlotte 6
Guarulhos 6
Jiaxing 6
Kolkata 6
Parma 6
Porto Alegre 6
Bari 5
Changsha 5
Gatchina 5
Kuala Lumpur 5
Totale 4.124
Salva come PNG Salva come JPEG
Nome #
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 213
A complex case of severe acute hepatitis with cholestasis in a genetically predisposed woman: Could curcumin be the trigger? 197
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 197
Pathology and molecular pathology of cholangiocarcinoma 164
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy? 159
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 145
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 143
Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib 142
Acute and Chronic Manifestations of Sympathetic Ophthalmia on Multimodal Imaging 141
Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity 133
Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations 123
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 121
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 119
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming 118
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 118
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis 117
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 117
Gene-Based Immune Reprogramming Overcomes the Immunosuppressive Microenvironment of Liver Metastases and Enables Protective T Cell Responses 116
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 116
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 114
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study 114
Cervix neuroendocrine carcinoma presenting with severe hypokalemia and Cushing’s syndrome 114
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis 112
Association of IgG4-related disease and systemic rheumatic disorders 112
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 111
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 108
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming 108
Survival Outcomes of Durvalumab in Combination with Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer: Real-World Results from a Single Italian Institution 104
A Re-Emerging Marker for Prognosis in Hepatocellular Carcinoma: The Add-Value of FISHing c-myc Gene for Early Relapse 104
N-Glycosylation Inhibition Hinders Immunosuppressive Activity of Tumor Microenvironment Cells and Improves CAR T Cell Efficacy 102
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions 101
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 100
Defining and predicting textbook outcomes for perihilar cholangiocarcinoma: analysis of factors improving achievement of desired postoperative outcomes 100
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib 98
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 98
HCC in metabolic syndrome: current concepts and future directions 97
Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos 96
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas 96
Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies 95
Minimally Invasive Approach Provides Oncological Benefit in Patients with High Risk of Very Early Recurrence (VER) After Surgery for Intrahepatic Cholangiocarcinoma (iCCA) 94
Cholangiocarcinoma: new perspectives for new horizons 94
The real life of precision medicine in biliary tract cancers: a tertiary referral centre experience 93
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241, (S0959804922002829), (10.1016/j.ejca.2022.05.004)] 92
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination 92
The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime 92
IFNalpha by In Vivo-Engineered Macrophages Abates Liver Metastases and Triggers Counter Regulatory Responses Limiting Efficacy 90
The oncologic burden of residual disease in incidental gallbladder cancer: An elastic net regression model to profile high-risk features 89
Synchronous Unicentric Castleman Disease and Inflammatory Hepatocellular Adenoma: a Case Report 89
Subcutaneous dirofilariosis in Italy: a diagnostic hypothesis to remind when the anamnesis is misleading 86
IFNalpha by in vivo-engineered macrophages abates liver metastases and triggers counter regulatory responses limiting efficacy 85
Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection 85
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma 84
3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations 83
Mucinous cystic neoplasms of the liver: A clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct 82
Same-session endoscopic diagnosis and symptom palliation in pancreato-biliary malignancies: Clinical impact of rapid on-site evaluation (ROSE) 80
Age influence on mice lung tissue response to Aspergillus fumigatus chronic exposure 80
Repeated administration of the food additive E171 to mice results in accumulation in intestine and liver and promotes an inflammatory status 80
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease 79
Clinicopathological features of adenosquamous pancreatic cancer 78
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma 78
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 78
Pure and mixed gallbladder neuroendocrine neoplasms: rare and orphan lesions 75
Late Breaking Abstract - Morphological and immunophenotypical features of lung tissue in early phase of COVID-19 75
IgG4-related autoimmune liver disease 68
Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease 68
Peribiliary glands pathology in a large series of end-stage alcohol-related liver disease 67
Heterogeneity of response and immune system activity during treatment with nivolumab in hepatocellular carcinoma: Results from a single-institution retrospective analysis 67
Lymphangiogenesis in Crohn's disease: An immunohistochemical study using monoclonal antibody D2-40 66
PDX-1 (Pancreatic/Duodenal Homeobox-1 Protein 1) 66
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis. 66
Endocrine neoplasms of the pancreas: pathologic and genetic features. 65
Preliminary results of the influence of the in vivo use of a lymphatic dye (Patent Blue V) in the surgical treatment of Crohn's disease 64
Hydroxyapatite/collagen composite is a reliable material for malar augmentation 63
Total portal vein replacement with peritoneal interposition graft during Whipple’s procedure for extrahepatic cholangiocarcinoma: a technical report 61
Paraoxonase-1 status in patients with hereditary hemochromatosis 58
Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes 57
Programmed death 1 (PD-1) and its ligand (PD-L1) as a new frontier in cancer Immunotherapy and challenges for the Pathologist: State of the art 56
Massive retinal gliosis in a young woman with congenital toxoplasmosis 56
Toxicity profile of adjuvant hypofractionated Image-Guided Radiotherapy in biliary tract carcinoma 53
Outcome of adjuvant hypofractionated radiotherapy concomitant to chemotherapy in bile duct carcinoma 53
Surgery for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: milestone changes in the last two decades potentially affecting current guidelines 53
Next-generation histopathologic diagnosis: A lesson from a hepatic carcinosarcoma 49
Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? 49
Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: A case report and review of the literature 48
Radial and Longitudinal Margins in Surgery of Perihilar Cholangiocarcinoma: When R1 Definition Is Associated with Different Prognosis 46
A viable human lung cancer tissue collection (LCTC) to accelerate translational research 41
Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience 22
Edoxaban-Induced Vanishing Bile Duct Syndrome: A Case Report With Review of the Literature 17
How to approach indeterminate biliary stenosis 10
Totale 8.205
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.993
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.993
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212 0 0 0 3 0 2 2 1 1 2 0 1
2022/202382 25 16 9 0 1 15 5 4 7 0 0 0
2023/2024449 11 65 50 41 20 33 19 42 4 18 64 82
2024/20251.507 169 41 63 69 85 117 260 177 170 86 112 158
2025/20265.046 356 308 221 628 603 183 452 386 1.302 255 150 202
2026/20271.100 182 260 283 375 0 0 0 0 0 0 0 0
Totale 8.205